TransMedics (TMDX) Gross Margin (2018 - 2026)

TransMedics has reported Gross Margin for 9 years, with the latest figure at 59.59% in Q2 2026.

• On a quarterly basis, Gross Margin fell 178.0% year-over-year to 59.59% in Q2 2026; TTM through Jun 2026 was 58.69%, a 110.0% decrease from a year earlier, with the FY2025 full-year figure at 59.92%, up 56.0% from the prior year.
• Gross Margin was 59.59% for Q2 2026 at TransMedics, up from 58.16% in the prior quarter.
• The five-year high for Gross Margin was 76.22% in Q1 2022, with the low at 55.94% in Q3 2024.
• Average Gross Margin over 5 years is 63.19%, with a median of 61.29% recorded in 2023.
• The largest YoY upside for Gross Margin was 1323 bps in 2022 against a maximum downside of 1577 bps in 2022.
• Over 5 years, Gross Margin stood at 65.99% in 2022, then retreated by 11 bps to 59.04% in 2023, then increased by 0 bps to 59.21% in 2024, then slipped by 2 bps to 58.11% in 2025, then climbed by 3 bps to 59.59% in 2026.
• The last three Gross Margin figures came in at 59.59% (Q2 2026), 58.16% (Q1 2026), and 58.11% (Q4 2025), per Business Quant data.